首页 | 本学科首页   官方微博 | 高级检索  
     


HER2-targeted therapy in breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors
Authors:Dorte Lisbet Nielsen  Michael Andersson  Claus Kamby
Affiliation:1. Department of Oncology, Herlev Hospital, University of Copenhagen, Herlev Ringvej 75, DK-2730 Herlev, Denmark;2. Department of Oncology, Finsencenter, Rigshospitalet, University of Copenhagen, Blegdamsvej 9, DK-2100 Copenhagen, Denmark
Abstract:
Keywords:Breast cancer   Human epidermal growth factor receptor 2   Lapatinib   Targeted therapy   Trastuzumab
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号